Delivery Order SPE2DB22D2007-SPE2DB25FJ3YG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,177.50 on September 11, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,676.12 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack) on April 24, 2025, with completion expected by April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract fulfills a critical medical supply need within the federal procurement system,...
- The Defense Logistics Agency awarded a delivery order valued at $6,947.25 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (two-pack units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Narcan (naloxone) is a critical emergency medication used to rapidly reverse opioid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Narcan 4 mg nasal spray (2-count packages) with a ceiling value of $1,318.80 and a firm fixed price structure. This delivery order, issued without a set-aside designation, is a competitive award that leverages AmerisourceBergen's established supply chain capabilities. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $2,615.88 delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,240.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (two-unit package) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to deliver this emergency...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) with a ceiling value of $1,667.87. This firm fixed price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,355.00 firm fixed-price delivery order for Narcan 4 mg nasal spray (2-pack units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3YGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Narcan (naloxone) is a critical emergency medication used to rapidly reverse opioid overdoses, making this supply component essential for military medical readiness and emergency response capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/14/25 |